Supplementary Data S6 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors

Supplementary Data S6 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors

<p>Supplementary Data 6 describes the patients included in the RNA sequencing analysis as well as AR and NEPC scores.</p>

Spremljeno u:

Bibliografski detalji
Glavni autor:	Naoual Menssouri (16617248) (author)
Daljnji autori:	Loïc Poiraudeau (16617251) (author), Carole Helissey (15122919) (author), Ludovic Bigot (16617254) (author), Jonathan Sabio (16617257) (author), Tony Ibrahim (16617260) (author), Cédric Pobel (16617263) (author), Claudio Nicotra (16617266) (author), Maud Ngo-Camus (16617269) (author), Ludovic Lacroix (15030059) (author), Etienne Rouleau (15009254) (author), Lambros Tselikas (15019536) (author), Anne Chauchereau (15022332) (author), Félix Blanc-Durand (15049400) (author), Alice Bernard-Tessier (16617272) (author), Anna Patrikidou (16617275) (author), Natacha Naoun (16617278) (author), Ronan Flippot (16426556) (author), Emeline Colomba (16617281) (author), Alina Fuerea (16617284) (author), Laurence Albiges (15047814) (author), Pernelle Lavaud (15119297) (author), Paul van de Wiel (16617287) (author), Eveline den Biezen (16617290) (author), Yvonne Wesseling-Rozendaal (16617293) (author), Santiago Ponce (16617296) (author), Stefan Michiels (9081965) (author), Christophe Massard (14952598) (author), Daniel Gautheret (10927940) (author), Fabrice Barlesi (15045504) (author), Fabrice André (15038378) (author), Benjamin Besse (15061674) (author), Jean-Yves Scoazec (15036392) (author), Luc Friboulet (15025943) (author), Karim Fizazi (15093615) (author), Yohann Loriot (15123021) (author)
Izdano:	2025
Teme:	Cancer Therapeutic Research and Development Drug Resistance Genitourinary Cancers Prostate cancer Translational Research
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!

Slični predmeti

Supplementary Data S1 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
od: Naoual Menssouri (16617248)
Izdano: (2025)

Supplementary Data S10 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
od: Naoual Menssouri (16617248)
Izdano: (2025)

Supplementary Data S11 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
od: Naoual Menssouri (16617248)
Izdano: (2025)

Supplementary Data S12 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
od: Naoual Menssouri (16617248)
Izdano: (2025)

Supplementary Data S13 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
od: Naoual Menssouri (16617248)
Izdano: (2025)

Supplementary Data S14 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
od: Naoual Menssouri (16617248)
Izdano: (2025)

Supplementary Data S2 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
od: Naoual Menssouri (16617248)
Izdano: (2025)

Supplementary Data S3 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
od: Naoual Menssouri (16617248)
Izdano: (2025)

Supplementary Data S4 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
od: Naoual Menssouri (16617248)
Izdano: (2025)

Supplementary Data S5 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
od: Naoual Menssouri (16617248)
Izdano: (2025)

Supplementary Data S7 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
od: Naoual Menssouri (16617248)
Izdano: (2025)

Supplementary Data S8 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
od: Naoual Menssouri (16617248)
Izdano: (2025)

Supplementary Data S9 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
od: Naoual Menssouri (16617248)
Izdano: (2025)

Supplementary Figure S1 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
od: Naoual Menssouri (16617248)
Izdano: (2025)

Supplementary Figure S2 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
od: Naoual Menssouri (16617248)
Izdano: (2025)

Supplementary Figure S3 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
od: Naoual Menssouri (16617248)
Izdano: (2025)

Supplementary Figure S4 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
od: Naoual Menssouri (16617248)
Izdano: (2025)

Supplementary Figure S1 from Phase I Study of Niraparib in Combination with Radium-223 for the Treatment of Metastatic Castrate-Resistant Prostate Cancer
od: Zachary Quinn (15052893)
Izdano: (2025)

Supplementary Figure S1 from Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer
od: Aurelius Omlin (14971513)
Izdano: (2025)

Supplementary Table S1 from Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer
od: Aurelius Omlin (14971513)
Izdano: (2025)

Supplementary Figure S1 from Phase II Trial of Pembrolizumab and Anti-CD3 x Anti-HER2 Bispecific Antibody-Armed Activated T Cells in Metastatic Castration-Resistant Prostate Cancer
od: Ulka N. Vaishampayan (15051039)
Izdano: (2025)

Supplementary Figure S2 from Phase II Trial of Pembrolizumab and Anti-CD3 x Anti-HER2 Bispecific Antibody-Armed Activated T Cells in Metastatic Castration-Resistant Prostate Cancer
od: Ulka N. Vaishampayan (15051039)
Izdano: (2025)

Supplementary Figure S3 from Phase II Trial of Pembrolizumab and Anti-CD3 x Anti-HER2 Bispecific Antibody-Armed Activated T Cells in Metastatic Castration-Resistant Prostate Cancer
od: Ulka N. Vaishampayan (15051039)
Izdano: (2025)

Supplementary Table S2 from Phase II Trial of Pembrolizumab and Anti-CD3 x Anti-HER2 Bispecific Antibody-Armed Activated T Cells in Metastatic Castration-Resistant Prostate Cancer
od: Ulka N. Vaishampayan (15051039)
Izdano: (2025)

Supplementary Table S1 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer
od: Sofie H. Tolmeijer (15313251)
Izdano: (2025)

Supplementary Table S2 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer
od: Sofie H. Tolmeijer (15313251)
Izdano: (2025)

Supplementary Table S3 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer
od: Sofie H. Tolmeijer (15313251)
Izdano: (2025)

Supplementary Table S1 from Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex
od: Michael D. Nyquist (16918265)
Izdano: (2025)

Supplemental Figures 1-4 from Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex
od: Michael D. Nyquist (16918265)
Izdano: (2025)

Supplementary File 2 from Bayesian Machine Learning Enables Identification of Transcriptional Network Disruptions Associated with Drug-Resistant Prostate Cancer
od: Charles Blatti (15292859)
Izdano: (2025)

Supplementary File 3 from Bayesian Machine Learning Enables Identification of Transcriptional Network Disruptions Associated with Drug-Resistant Prostate Cancer
od: Charles Blatti (15292859)
Izdano: (2025)

Supplementary File 4 from Bayesian Machine Learning Enables Identification of Transcriptional Network Disruptions Associated with Drug-Resistant Prostate Cancer
od: Charles Blatti (15292859)
Izdano: (2025)

Supplementary Movie S1 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
od: Jesse C. Patterson (14962862)
Izdano: (2025)

Supplementary Movie S2 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
od: Jesse C. Patterson (14962862)
Izdano: (2025)

Supplementary Movie S3 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
od: Jesse C. Patterson (14962862)
Izdano: (2025)

Supplementary Movie S4 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
od: Jesse C. Patterson (14962862)
Izdano: (2025)

Supplementary Movie S5 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
od: Jesse C. Patterson (14962862)
Izdano: (2025)

Supplementary Movie S6 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
od: Jesse C. Patterson (14962862)
Izdano: (2025)

Supplementary Movie S7 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
od: Jesse C. Patterson (14962862)
Izdano: (2025)

Supplementary Movie S8 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
od: Jesse C. Patterson (14962862)
Izdano: (2025)

Cannot write session to /tmp/vufind_sessions/sess_9gn55g5iorjgn0ohdgdsadp7et